Health Canada Warns of Sale of Unauthorized Smoking Cessation Product
Posted on: Saturday, 28 July 2007, 06:22 CDT
OTTAWA (CP) - Health Canada is advising consumers to avoid use of an unauthorized quit-smoking product, citing a potential health risk.
Resolve contains an unacceptable amount of the ingredient "Cestemonol-350," which in excessive amounts could damage the kidney, liver or red blood cells, the agency said Friday.
Health Canada warns Resolve is adverstised as a natural quit-smoking aid available in Cool Peppermint and Wild Cherry flavours, and has been sold in retail stores across the country and on the Internet.
The federal health watchdog says the company has so far refused to recall the products, and it will take further action to remove it from the market.
Officials advise retailers to remove the product from their shelves, and consumers to return it to the point of sale.
Health Canada points out drugs and natural health products authorized for sale in Canada will have special eight-digit identification numbers on the label.
Source: Canadian Press
Related Articles
- Health Canada Approves Teva's Azilect
- Teva Announces Health Canada Approves AZILECT(R) (Rasagiline) for Parkinson's Disease
- Health Canada Gives Go-Ahead for ProMetic Anemia Trial
- Health Canada Agrees to Let Yanked ADHD Adderall Back on Canadian Market
- Health Canada Chooses a PWGSC Server Monitoring Service Powered By NUVO-Helps Department Assure Availability of Government Service to the Public
- Impotence Drugs Viagra, Cialis, Levitra Could Cause Blindness: Health Canada
- Pharming Receives CTA Approval From Health Canada for Recombinant Human C1 Inhibitor
- Health Canada Warns About Use of Pain Killer Celebrex Due to Heart Risk
- Health Canada Warns Consumers About Use of Drug Celebrex Due to Heart Risk
- Isotechnika Inc. Receives No Objection Letter From Health Canada for Phase III Psoriasis Trial
 |
 |
User Comments (0)
RSS Feeds